Dr. Majid is Chief of the Section of Interventional Pulmonology (Division of Thoracic Surgery and Interventional Pulmonology) at the Beth Israel Deaconess Medical Center, and Associate Professor of Medicine and Surgery at Harvard Medical School. Interventional Pulmonology is the major focus of Dr. Majid’s clinical practice, research and education.
Dr. Majid is actively involved in the innovation of new technologies, as well as industry-sponsored and clinician-initiated research. Currently, he is the principal investigator and co-investigator in multiple clinical trials. He has extensive experience in bronchoscopic lung volume reduction procedures, having completed more that 100 of these procedures. In addition, he was the site PI for multiple bronchoscopic lung volume reduction (BLVR) clinical trials including LIBERATE, EMPROVE and RENEW. In collaboration with his colleagues from Thoracic Surgery, he has pioneered the concept of completing the interlobar fissure (via VATS or RATS and stapling) for patients who are otherwise candidates for BLVR but have collateral ventilation in the target lobe and is currently the PI for the COMPLETE-1 and SAVED clinical trials.
At the national level, he has introduced several innovative approaches for diagnosis, such as the validation of dynamic flexible bronchoscopy for the diagnosis of tracheobronchomalacia (TBM). Furthermore, he has described novel minimally invasive endoscopic techniques including the use of cryotechnology for removal of metallic stents, use of linear EBUS for fiducial marker placement, use of rigid bronschoscopy to guide tracheostomy tube placement and external fixation of cervical airway stents.
Dr. Majid has extensive experience in education and training. He was the program Director for more than 10 years of the Harvard Combined Beth Israel Deaconess Medical Center (BIDMC) -Massachusetts General Hospital (MGH) Fellowship Program in Interventional Pulmonology, which is the largest training program in the nation. To date, the program has trained 46 authorities in the field, 17 of whom are chiefs of Interventional Pulmonology at major academic medical centers in the United States and around the world (Canada, Kuwait and Saudi Arabia).